Y
Ya Cao
Researcher at Central South University
Publications - 399
Citations - 12057
Ya Cao is an academic researcher from Central South University. The author has contributed to research in topics: Nasopharyngeal carcinoma & Cancer. The author has an hindex of 52, co-authored 276 publications receiving 8809 citations. Previous affiliations of Ya Cao include Chinese Ministry of Education & National Health and Family Planning Commission.
Papers
More filters
Journal ArticleDOI
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
Shao-Lai Zhou,Zheng-Jun Zhou,Zhi-Qiang Hu,Xiao-Wu Huang,Zheng Wang,Er-Bao Chen,Jia Fan,Ya Cao,Zhi Dai,Jian Zhou +9 more
TL;DR: TAN-conditioned media, as well as recombinant CCL2 and CCL17, increased the migratory activity of the macrophages and T-regulatory cells from patients or mice with HCC to a greater extent that PBN- conditioned media.
Journal ArticleDOI
Emerging roles of lipid metabolism in cancer metastasis
Xiangjian Luo,Xiangjian Luo,Can Cheng,Can Cheng,Zheqiong Tan,Zheqiong Tan,Namei Li,Namei Li,Min Tang,Min Tang,Lifang Yang,Lifang Yang,Ya Cao,Ya Cao +13 more
TL;DR: The present review is focused on key enzymes in lipid metabolism associated with metastatic disease pathogenesis and the function of an important membrane structure-lipid raft in mediating tumor aggressive progression.
Journal ArticleDOI
Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
Min Wang,Chao Mao,Lianlian Ouyang,Yating Liu,Weiwei Lai,Na Liu,Ying Shi,Ling Chen,Desheng Xiao,Fenglei Yu,Xiang Wang,Hu Zhou,Ya Cao,Shuang Liu,Qin Yan,Yongguang Tao,Bin Zhang +16 more
TL;DR: It is demonstrated that a nuclear lncRNA LINC00336 is upregulated in lung cancer and functions as an oncogene by acting as a competing endogenous RNA (ceRNAs) and found that MIR6852 inhibited cell growth by promoting ferroptosis.
Journal ArticleDOI
A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53.
Chao Mao,Xiang Wang,Yating Liu,Min Wang,Bin Yan,Yiqun Jiang,Ying Shi,Yi Shen,Xiaoli Liu,Weiwei Lai,Rui Yang,Desheng Xiao,Yan Cheng,Shuang Liu,Hu Zhou,Ya Cao,Weishi Yu,Kathrin Muegge,Herbert Yu,Yongguang Tao +19 more
TL;DR: It is demonstrated that the cytosolic lncRNA P53RRA is downregulated in cancers and functions as a tumor suppressor by inhibiting cancer progression, thus regulating p53 modulators to suppress cancer progression.
Journal ArticleDOI
EGLN1/c-Myc Induced Lymphoid-Specific Helicase Inhibits Ferroptosis through Lipid Metabolic Gene Expression Changes
Yiqun Jiang,Chao Mao,Rui Yang,Bin Yan,Ying Shi,Xiaoli Liu,Weiwei Lai,Yating Liu,Xiang Wang,Desheng Xiao,Hu Zhou,Yan Cheng,Fenglei Yu,Ya Cao,Shuang Liu,Qin Yan,Yongguang Tao +16 more
TL;DR: The molecular basis of the c-Myc/EGLN1-mediated induction of LSH expression that inhibits ferroptosis is elucidated, which can be exploited for the development of therapeutic strategies targeting ferroPTosis for the treatment of cancer.